Pharma & Biotech

Iovance Biotherapeutics shares are confronting significant pressure from three distinct fronts as the company prepares to present at today's Wells...

The pharmaceutical sector is closely monitoring the impending acquisition of Verona Pharma by industry giant Merck & Co., a transaction...

Tango Therapeutics faced significant selling pressure as investors reacted to disappointing second-quarter 2025 financial results. The biotechnology company reported both...

Shares of CEL-SSCI experienced a notable decline of 4.99% in Tuesday's trading session, closing at $11.24. The stock demonstrated significant...

Inovio Pharmaceuticals shares edged higher in early trading, gaining 1.48% to reach $2.75. This modest uptick follows the company's participation...

In a significant advancement for pediatric oncology, Jazz Pharmaceuticals has secured accelerated FDA approval for its novel treatment targeting a...

While Zevra Therapeutics recently announced encouraging clinical results for its lead drug candidate, MIPLYFFA, its stock performance tells a contrasting...

Enanta Pharmaceuticals is navigating a significant leadership transition following the passing of its long-time Chief Financial Officer, Paul J. Mellett...

Lifecore Biomedical finds itself at a crossroads, navigating a complex landscape defined by strategic progress and immediate financial pressures. The...

Lyell Immunopharma has initiated a pivotal Phase 3 clinical trial for its lead CAR T-cell therapy, marking a significant strategic...